REZOLUTE, INC.
RZLT US76200L3096
United States 19808
US-DE WILMINGTON C/O THE COMPANY CORPORATION
251 LITTLE FALLS DRIVE
Registration Number 5268822
Rezolute Inc is a biopharmaceutical company. The company develops novel, sustained-release injectable therapies. It applies proprietary formulation and manufacturing capabilities to known, well-characterized molecules to create differentiated, patent-protected therapies that have the potential to significantly improve existing standards of care. Its pipeline products include RZ358 and RZ402.
Annual Performance 1
| 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| -63% | -59% | -47% | 385% | 0% |
Annual Insiders Turnover, USD 2
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
Transactions: 37 Insiders: 6
| Person | Price | Shares | Total | Published | Completed |
|---|---|---|---|---|---|
| Hogenhuis Wladimir |
2.92 USD |
6,758 Bought |
19,733 USD |
01/04/2025 | 31/03/2025 |
| Elam Nevan C |
2.85 USD |
12,302 Bought |
34,999 USD |
27/03/2025 | 27/03/2025 |
| Evans Daron |
2.88 USD |
10,000 Bought |
28,800 USD |
26/03/2025 | 26/03/2025 |
| Evans Daron |
2.89 USD |
10,000 Bought |
28,900 USD |
26/03/2025 | 26/03/2025 |
| Hogenhuis Wladimir |
4.70 USD |
10,000 Bought |
47,000 USD |
16/02/2025 | 18/02/2025 |
| Evans Daron CFO |
4.29 USD |
10,000 Bought |
42,900 USD |
18/12/2024 | 18/12/2024 |
| Evans Daron |
4.60 USD |
9,000 Bought |
41,400 USD |
12/12/2024 | 12/12/2024 |
| Evans Daron CFO |
5.04 USD |
10,549 Bought |
53,167 USD |
09/12/2024 | 09/12/2024 |
| Hogenhuis Wladimir |
4.70 USD |
4,259 Bought |
20,017 USD |
24/09/2024 | 24/09/2024 |
| Kim Young-Jin |
4.00 USD |
1,250,000 Bought |
5,000,000 USD |
25/06/2024 | 25/06/2024 |